Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 2,196 | 7,195 | 13,260 | 9,510 | 6,433 |
| Cost of Goods | 1,435 | 84 | 481 | 774 | 638 |
| Gross Profit | 761 | 7,111 | 12,779 | 8,736 | 5,795 |
| Operating Expenses | 58,246 | 60,007 | 67,474 | 48,995 | 36,311 |
| Operating Income | -57,050 | -52,812 | -54,214 | -39,485 | -29,878 |
| Other Income | 2,292 | 950 | 684 | 40 | -4,273 |
| Pre-tax Income | -54,758 | -51,862 | -53,530 | -39,445 | -34,151 |
| Net Income Continuous | -54,758 | -51,862 | -53,530 | -39,445 | -34,151 |
| Net Income | $-54,758 | $-51,862 | $-53,530 | $-39,445 | $-34,151 |
| EPS Basic Total Ops | -1.14 | -1.75 | -2.47 | -2.06 | -4.56 |
| EPS Basic Continuous Ops | -1.14 | -1.75 | -2.47 | -2.06 | -4.56 |
| EPS Diluted Total Ops | -1.14 | -1.75 | -2.47 | -2.06 | -4.56 |
| EPS Diluted Continuous Ops | -1.14 | -1.75 | -2.47 | -2.06 | -4.56 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.75 | -2.47 | -2.06 | -4.56 |
| EBITDA(a) | $-57,265 | $-52,487 | $-53,784 | $-39,242 | $-29,640 |